Drawing for GENEMO

USPTO serial 87978594

GENEMO

Reviewed by CopyMark Law Group

Reg. 5613757Status 710
Filing date
Status date
Registration date
Nov 20, 2018
Examiner
BERLIN, JUSTIN E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GENEMO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory useSECTION 8 - CANCELLEDAug 24, 2018
005clinical diagnostic reagents and clinical diagnostic kits comprised of clinical diagnostic reagents; reagents for medical use and medical diagnostics or screening kits comprised of reagents for medical diagnostics and screening use; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposesSECTION 8 - CANCELLEDAug 24, 2018
010medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer screening, IVF preimplantation genetic screening, and cancer recurrence monitoringSECTION 8 - CANCELLEDAug 24, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2025C8..CANCELLED SEC. 8 (6-YR)—
Jan 18, 2024CRAFAMENDMENT CORRESPONDENCE ENTERED—
Nov 20, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 8, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 7, 2019CORVREVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED—
Feb 25, 2019EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 20, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 16, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 15, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 19, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 19, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 19, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 27, 2018IUAFUSE AMENDMENT FILED—
Aug 27, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Aug 27, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 27, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 2, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 2, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 27, 2017ALIEASSIGNED TO LIE—
Nov 17, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 8, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 29, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 29, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 19, 2017DOCKASSIGNED TO EXAMINER—
Jul 27, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance